Pediatrix Medical Group Inc. logo

Pediatrix Medical Group Inc.

MD | NYSE
Chart Builder DCF Calculator
$25.77
-$0.16 (-0.62%)
At close: Sep 21, 2026, 4:00 PM ET
$25.77
$0 (0.00%)
After-hours: Sep 21, 2026, 4:00 PM ET

Market Data

Market Cap
$2.13B
Enterprise Value
$2.33B
Beta
0.65
Average Volume
829.09K
Shares Outstanding (Diluted)
81.41M
Shares Change YoY
-6.27%
Institutional Ownership
100.00%
Exchange
NYSE
ISIN
US58502B1061

Price Performance

Price Change 1M
-4.0%
Price Change 3M
8.0%
Price Change 6M
21.6%
Price Change YTD
21.0%
Price Change 1Y
55.6%
Price Change 3Y
108.2%
Price Change 5Y
-10.7%
1M CAGR (ann.)
-2.2%
1Y CAGR (ann.)
60.3%
5Y CAGR (ann.)
-2.5%
All-Time CAGR
0.8%

Valuation

PE Ratio
12.33
Forward PE
10.14
PEG Ratio
0.19
Forward PEG
3.08
PS Ratio
1.08
Forward PS
1.10
PB Ratio
2.40
P/FCF Ratio
9.24
P/Adj. FCF Ratio
10.14
P/OCF Ratio
8.29
EV/Sales
1.20
EV/EBIT
9.56
EV/EBITDA
8.73
EV/FCF
10.19
Earnings Yield
8.1%
FCF Yield
10.8%
Adj. FCF Yield
9.9%

Financial Health

Net Debt
$180.05M
Total Debt
$619.96M
Cash & Short-Term Investments
$404.2M
Total Assets
$2.13B
Current Ratio
1.32
Quick Ratio
1.32
Debt / Equity Ratio
0.70
Debt / EBITDA
2.32
Debt / FCF
2.71
OCF / Debt
0.40
Interest Coverage
8.01
Altman Z-Score
2.40
Piotroski F-Score
7

Margins & Profitability

Gross Profit Margin
25.9%
Operating Profit Margin
11.6%
EBITDA Margin
13.7%
Net Profit Margin
9.0%
FCF Margin
11.7%
Adj. FCF Margin
10.7%
SBC / Revenue
1.0%
SBC Impact (per share)
-8.8%

Returns

Return on Assets
8.2%
Return on Equity
19.9%
Return on Invested Capital
9.6%
Return on Capital Employed
13.9%
Return on Tangible Assets
20.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
-0.8%
Revenue CAGR 5Y
1.6%
Revenue CAGR 10Y
-4.2%
EPS CAGR 3Y
19.0%
EPS CAGR 5Y
44.1%
EPS CAGR 10Y
-5.2%
FCF CAGR 3Y
18.1%
FCF CAGR 5Y
17.4%
FCF CAGR 10Y
-4.4%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
33
EPS Growth Next 3Y
0.9%
Revenue Growth Next 3Y
4.6%
Earnings Date
Nov 1, 2026
EPS Estimate (next Q)
$0.63
EPS Growth Est (next Q)
-6.0%
Revenue Est (next Q)
$498.18M
Revenue Growth Est (next Q)
1.1%

Fair Value Estimates

Graham Number
$22.84
Graham Upside
-11.4%
Lynch Fair Value
$52.25
Lynch Upside
102.8%
Price Target
$26.60
Price Target Upside
3.2%

Cash Flow

Operating Cash Flow
$247.21M
Free Cash Flow
$228.96M
Adj. Free Cash Flow
$208.73M
FCF Per Share
$2.88
OCF Per Share
$3.11
OCF/S Ratio
12.7%

Income Statement

Revenue
$1.95B
Gross Profit
$506.14M
Operating Income
$226.23M
EBITDA
$267.04M
Net Income
$174.81M
EPS (Diluted)
$2.09
Revenue / Employee
$455.75K
Profit / Employee
$40.84K
Employees
4,280

© 2026 bestshares.com. All rights reserved.